Catalyst Wire Dossier Catalyst Wire Dossier

Dexlansoprazole (Dexilant)

Dexlansoprazole · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dexlansoprazole (Dexilant), covering 2012-04-05 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old [Phase 2]

See pricing